Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), End User, Region - Global Forecast to 2025. Global Primary Cells market is projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7%. Primary cells are widely used in applications such as 3D cell culture, virology, cancer research, stem cell therapy, and tissue replacement among others.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960

Browse and in-depth TOC on "Primary Cells Market"

108 - Tables

34 - Figures

179 - Pages

The Growth in this market is largely driven by the rising prevalence of cancer, increasing focus on the development of novel cancer therapies, and rising adoption of primary cells over cell lines. Emerging economies such as China and Japan are providing lucrative opportunities for the players operating in the Primary Cells Market.

The human primary cells segment accounted for the largest share of the Primary Cells Market, by origin segment

Based on origin, the Primary Cells Market is segmented into human and animal primary cells. The human primary cells segment accounted for the largest share in the Primary Cells Market. The growing application areas of human stem cells and the rising incidence of cancer are the major factors driving the growth of this segment.

Hepatocytes segment to register the highest growth rate during the forecast period

Based on type, the Primary Cells Market is segmented into hematopoietic cells, dermatocytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and other primary cells. the hepatocytes segment accounted for the highest growth rate.

The life science research companies segment accounted for the largest share of the Primary Cells Market, by end user segment

Increasing cancer research in life science research companies, the increasing number of RD facilities, high adoption of primary cells in cell-based experiments, and the increasing investments of companies in cell-based research are the major factors driving the growth of this segment.

Get 10% Customization Research Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32854960

North America is the largest regional market for Primary Cells Market

North America accounted for the largest share in the Primary Cells Market. The growth in the North American Primary Cells Market can be attributed to increasing funding for cancer research, growing life science research sector, expansion of the healthcare sector, and the high adoption of stem cell therapy cell immunotherapies for the treatment of cancer and chronic diseases.

Key Market Players

The major players operating in Primary Cells Market are  Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics, Inc. (US), PromoCell GmbH (Germany), HemaCare Corporation (US), ZenBio, Inc. (US), STEMCELL Technologies, Inc. (Canada), Corning Incorporated (US), AllCells (US), American Type Culture Collection (US),